Amorchem, A BIOQuébec Member, announces the financing of a new university project AmorChem Reinforces Its Innate Immunity Franchise with an Investment in Checkpoint Control Target SRSF3. Read More NewsCatherine LamontagneFebruary 18, 2019BIOOQuébecAmorchem, Univeristé Laval, CERVO